News

While humans have used opioids for their medicinal benefits, the drug has paved the path of both treatment and tragedy.
Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Drug repurposing, or finding new uses for existing medications, could potentially lower the cost of prescription drugs and medical expenses and accelerate the discovery of new treatments. In the ...
The iPad Air sits in the sweet spot of Apple’s tablet range. Much like the MacBook Air, which remains the best iPad for most people in the laptop range, the iPad Air is likely to be the perfect ...
I’m PCMag’s managing editor for consumer electronics content, overseeing an experienced team of reviewers and product testers. I’ve been covering tech for more than 22 years. Prior to PCMag ...
"If we formulate these products into familiar dosage forms such as tablets, we add more value to these earlier products and make them accessible to the general public,” he added. The pill, named as ...
Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...
5G tablets offer seamless connectivity, making them ideal for work, entertainment, and communication. With larger screens than smartphones, they provide an immersive experience for streaming ...
Ketamine has gained attention in recent years for its potential in treating depression, specifically after FRIENDS actor Matthew Perry's death in 2023 due to the acute dose of this drug.
“Kudos to them that they knew what to look for.” Podcast: New lasso-shaped antibiotic kills drug-resistant bacteria The latest molecule targets bacteria’s protein-making factory, the ...
UIC researchers working with collaborators at McMaster University in Canada determined how the new antibiotic works and why the drug evades bacterial resistance. "The holy grail in the field is to ...